Protein-Protein Interactions Icon

Cambridge Healthtech Institute’s Inaugural

Protein-Protein Interactions

Small Molecule Discovery for Difficult Drug Targets

4 - 5 DECEMBER 2024

 

 

Protein-protein interactions (PPIs) as drug targets are disease-relevant complexes of proteins bound to one another, and sometimes to DNA or RNA as well. PPIs are difficult for medicinal chemists to design or discover drugs against because there is no enzymatic site to inhibit. Furthermore, the PPIs usually have flat interaction surfaces making it harder for small molecules to bind the PPIs. At CHI's Protein-Protein Interactions conference join a global community of medicinal, biophysical and structural chemists to share insights, successes and lessons learned from working on these hard-to-drug targets.






For more details on the conference, please contact:

Anjani Shah, PhD

Senior Conference Director

Cambridge Healthtech Institute

Phone: (+1) 781-247-6252

Email: ashah@healthtech.com

 

For sponsorship information, please contact:

Kristin Skahan

Senior Business Development Manager

Cambridge Healthtech Institute

Phone: (+1) 781-972-5431

Email: kskahan@healthtech.com


Register Early and Save
Next-Gen Degraders & Molecular Glues
Protein-Protein Interactions

Learn About Our U.S. Event
Register Early and Save